Filing Details
- Accession Number:
- 0001179110-20-008845
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-10 19:49:07
- Reporting Period:
- 2020-08-06
- Accepted Time:
- 2020-08-10 19:49:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711968 | Leonard Steven Chapman | C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-06 | 2,188 | $9.59 | 26,002 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-06 | 4,469 | $10.41 | 30,471 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-06 | 2,083 | $10.73 | 32,554 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-06 | 6,105 | $9.29 | 38,659 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-06 | 3,125 | $13.01 | 41,784 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-06 | 13,542 | $20.27 | 55,326 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-06 | 36,329 | $55.00 | 18,997 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-08-06 | 20,312 | $13.01 | 39,309 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-06 | 25,236 | $55.00 | 14,073 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-06 | 2,188 | $0.00 | 2,188 | $9.59 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-06 | 4,469 | $0.00 | 4,469 | $10.41 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-06 | 2,083 | $0.00 | 2,083 | $10.73 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-06 | 6,105 | $0.00 | 6,105 | $9.29 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-06 | 3,125 | $0.00 | 3,125 | $13.01 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-06 | 13,542 | $0.00 | 13,542 | $20.27 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-06 | 20,312 | $0.00 | 20,312 | $13.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,188 | 2026-04-07 | No | 4 | M | Direct | |
| 27,929 | 2027-06-08 | No | 4 | M | Direct | |
| 12,500 | 2027-07-13 | No | 4 | M | Direct | |
| 73,261 | 2028-03-08 | No | 4 | M | Direct | |
| 69,791 | 2029-01-10 | No | 4 | M | Direct | |
| 85,416 | 2029-04-11 | No | 4 | M | Direct | |
| 101,562 | 2020-01-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2019 as amended on February 28, 2020.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on April 1, 2017 and the remaining shares vest in 36 equal monthly installments thereafter.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on March 21, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on March 12, 2018 and the remaining shares vest in 36 equal monthly installments thereafter.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on March 22, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.
- This option becomes exercisable, if at all, upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. The first milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $2,000,000,000 and (ii) the Issuer's outstanding shares as most recently reported on the Issuer's Form 10-Q or Form 10-K (the "Capitalization"). The second milestone is the Issuer's stock price equaling or exceeding the quotient of (i) $3,000,000,000 and (ii) the Capitalization (the "Performance Vesting Conditions"). As of June 8, 2020, the Company's Board of Director determined the performance criteria had been met with respect to 62,500 additional shares.
Billionaire Hedge Funds
